Protagonist Therapeutics, Inc
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On March 17, 2022, Don Kalkofen, the Chief Financial Officer of Protagonist Therapeutics, Inc. (the “Company”), submitted his notice of resignation from his position as Chief Financial Officer of the Company to be effective on April 1, 2022.
Extracted from this filing and checked against the source text.
Don Kalkofen departed as Chief Financial Officer at Protagonist Therapeutics, Inc.
On March 17, 2022, Don Kalkofen, the Chief Financial Officer of Protagonist Therapeutics, Inc. (the “Company”), submitted his notice of resignation from his position as Chief Financial Officer of the Company to be effective on April 1, 2022.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.